title: [Autologous transplant with BEAM protocol in lymphoma].
authors.affiliation: Servicio de Hematología, Hospital Universitario de Salamanca.
authors.forename: D
authors.initials: D
authors.lastname: Caballero
authors.forename: V
authors.initials: V
authors.lastname: Rubio
authors.forename: J
authors.initials: J
authors.lastname: Rifon
authors.forename: I
authors.initials: I
authors.lastname: Heras
authors.forename: R
authors.initials: R
authors.lastname: García-Sanz
authors.forename: B
authors.initials: B
authors.lastname: Vidriales
authors.forename: J A
authors.initials: JA
authors.lastname: Pérez-Simón
authors.forename: C
authors.initials: C
authors.lastname: del Cañizo
authors.forename: M
authors.initials: M
authors.lastname: González
authors.forename: A
authors.initials: A
authors.lastname: León
authors.forename: E
authors.initials: E
authors.lastname: Jean-Paul
authors.forename: E
authors.initials: E
authors.lastname: Rocha
authors.forename: V
authors.initials: V
authors.lastname: Vicente
authors.forename: J F
authors.initials: JF
authors.lastname: San Miguel
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002330:Carmustine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality; D006689:Hodgkin Disease / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D011034:Podophyllotoxin / Q000008:administration & dosage; D011379:Prognosis; D012074:Remission Induction; D019172:Transplantation Conditioning / Q000009:adverse effects; D014182:Transplantation, Autologous
chemical_list: D003561:Cytarabine; D011034:Podophyllotoxin; D008558:Melphalan; D002330:Carmustine